Pay in 4 interest-free payments of $5.53 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
12 weeks 84 syringes 1 syringe per injection
The conversion table above is primarily a resource for patients using compounded tirzepatide drawn from a vial with an insulin syringe
Zepbound (tirzepatide) is a glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist approved by the FDA for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity
Safety Considerations and Provider-Supervised Dosing Adjustments Tirzepatide may increase pancreatitis risk in susceptible individuals and requires caution in those with personal or family history of medullary thyroid carcinoma
Para Rybelsus (semaglutide oral), espere al menos 30 minutos despus de tomarlo antes de usar otros medicamentos orales
US$ 23.78
US$ 26.84
US$ 26.37
